Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

BME/ROVI stock hub

BME/ROVI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BME/ROVIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.2B

Madrid Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BME/ROVI

In the news

Latest news · BME/ROVI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E21.4

P25 13.9P50 15.9P75 23.2

Trailing P/E24.4

P25 19P50 22.9P75 51.7

ROE20.5

P25 -2.5P50 6.1P75 23.1

ROIC17.4

P25 -1.5P50 7.5P75 17.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BME/ROVI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

232

Groups with data

Currency

EUR

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Spain
Country code	ES
Employees	2,045
Employees Change	51%
Employees Change Percent	2.56
Enterprise value	EUR 3.2B
Exchange	Madrid Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	ES0157261019
Last refreshed	2026-05-10
Market cap	EUR 3.2B
Price	EUR 62.85
Price currency	EUR
Rev Per Employee	370,913.41x
Sector	Healthcare
Sic	2834
Symbol	bme/ROVI
Website	https://www.rovi.es

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.1%
EV Earnings	24.61x
EV/EBIT	20.24x
EV/EBITDA	17.67x
EV/FCF	27.84x
EV/Sales	4.38x
FCF yield	3.63%
Forward P/E	21.44x
P/B ratio	4.68x
P/E ratio	24.39x
P/S ratio	4.34x
PE Ratio10 Y	30.61x
PE Ratio3 Y	22.56x
PE Ratio5 Y	21.82x
PEG ratio	1.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.61%
EBITDA Margin	24.75%
FCF margin	15.73%
Gross margin	63.97%
Gross Profit	EUR 474.1M
Gross Profit Growth	0.35%
Gross Profit Growth Q	2.75%
Gross Profit Growth3 Y	-2.64%
Gross Profit Growth5 Y	13.47%
Net Income	EUR 131.8M
Net Income Growth	-5.86%
Net Income Growth Q	-47.63%
Net Income Growth Years	1%
Net Income Growth3 Y	-12.1%
Net Income Growth5 Y	13.18%
Pretax Margin	23.3%
Profit Margin	17.79%
Profit Per Employee	EUR 65,976
Profitable Years	22
ROA	11.5
Roa5y	15.81
ROCE	20.57
ROE	20.48
Roe5y	31.03
ROIC	17.42
Roic5y	30.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	16.82%
Cagr15y	19.82%
Cagr1y	24.1%
Cagr3y	15.27%
Cagr5y	6.74%
Div CAGR10	21%
Div CAGR3	-10.26%
Div CAGR5	10.95%
EPS Growth Years	1
FCF Growth	39.98%
FCF Growth Q	-49.37%
FCF Growth3 Y	3.73%
FCF Growth5 Y	29.88%
OCF Growth	27.98%
OCF Growth Q	-31.23%
OCF Growth10 Y	16.31%
OCF Growth3 Y	4.67%
OCF Growth5 Y	20.37%
Revenue Growth	-3.44x
Revenue Growth Q	-1.55x
Revenue Growth Years	0x
Revenue Growth3 Y	-3.07x
Revenue Growth5 Y	10.51x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.85
Assets	EUR 926.3M
Cash	EUR 97.4M
Current Assets	EUR 539.3M
Current Liabilities	EUR 147.5M
Debt	EUR 114.4M
Debt EBITDA	EUR 0.62
Debt Equity	EUR 0.17
Debt FCF	EUR 0.98
Equity	EUR 686.7M
Interest Coverage	58.95
Liabilities	EUR 239.6M
Long Term Assets	EUR 387M
Long Term Liabilities	EUR 92.1M
Net Cash	EUR -17M
Net Cash By Market Cap	EUR -0.53
Net Debt EBITDA	EUR 0.09
Net Debt Equity	EUR 0.02
Net Debt FCF	EUR 0.15
Tangible Book Value	EUR 638.8M
Tangible Book Value Per Share	EUR 12.49
WACC	5.73

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.66
Inventory Turnover	0.9
Net Working Capital	EUR 322.1M
Quick ratio	1.77
Working Capital	EUR 391.7M
Working Capital Turnover	EUR 2.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	-15.28%
Dividend Growth Years	0%
Dividend per share	EUR 0.94
Dividend Years	18
Dividend Yield	1.49%
Ex Div Date	2026-07-13
Last Dividend	EUR 0.76
Payout Frequency	Annual
Payout Ratio	36.28%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	373.23%
1Y total return	24.08%
200-day SMA	66.95
3Y total return	53.19%
50-day SMA	80.47
50-day SMA vs 200-day SMA	50over200
5Y total return	38.53%
All Time High	94.8
All Time High Change	-33.7%
All Time High Date	2024-05-27
All Time Low	3.54
All Time Low Change	1,675.42%
All Time Low Date	2009-03-02
ATR	2.88
Beta	0.3
Beta1y	1.24
Beta2y	0.8
Ch YTD	-1.02
High	63.6
High52	86.7
High52 Date	2026-04-21
High52ch	-27.51%
Low	61.5
Low52	50.9
Low52 Date	2025-05-23
Low52ch	23.48%
Ma50ch	-21.89%
Price vs 200-day SMA	-6.13%
RSI	15.74
RSI Monthly	48.24
RSI Weekly	40.59
Sharpe ratio	0.62x
Sortino ratio	0.98
Total Return	1.49%
Tr YTD	-1.02
Tr15y	1,406.66%
Tr1m	-22.26%
Tr1w	-20.84%
Tr3m	-13.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 160.2M
Operating Income Growth	-12.22
Operating Income Growth Q	-56.75
Operating Income Growth3 Y	-13.35
Operating Income Growth5 Y	11.72
Operating margin	21.61

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	16,296,127%
Net Borrowing	-308,000
Shares Institutions	15.34%
Shares Out	51,149,498
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 116.5M
Average Volume	182,238.2x
Bv Per Share	13.18
CAPEX	EUR -64.7M
Ch10y	329
Ch15y	1,157
Ch1m	-22.26
Ch1w	-20.84
Ch1y	22.4
Ch3m	-13.73
Ch3y	45.82
Ch5y	29.45
Ch6m	14.38
Change	-0.32%
Change From Open	-0.24
Close	63.05
Days Gap	-0.08
Depreciation Amortization	23,278,000
Dollar Volume	14,145,021
Earnings Date	2026-05-06
EBIT	EUR 160.2M
EBITDA	EUR 183.4M
EPS	EUR 2.58
F Score	5
FCF	EUR 116.5M
FCF EV Yield	3.59x
FCF Per Share	EUR 2.28
Financing CF	-47,000,000
Fiscal Year End	December
Founded	1,946
Goodwill	2,702,000
Graham Number	27.64014
Graham Upside	-56.02
Income Tax	EUR 41M
Investing CF	-66,108,000
Is Primary Listing	1
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Lynch Fair Value	EUR 33.97
Lynch Upside	-45.95
Ma150	70.19
Ma150ch	-10.46%
Ma20	79.95
Ma20ch	-21.39%
Net CF	68,085,000
Next Earnings Date	2026-07-23
Open	63
P FCF Ratio	27.58
P OCF Ratio	17.74
Payment Date	2025-07-16
Position In Range	64.29
Ppne	329,257,000
Price Date	2026-05-08
Price EBITDA	EUR 17.52
Ptbv Ratio	5.03
Relative Volume	1.26x
Revenue	741,085,000x
Tax By Revenue	5.53x
Tax Rate	23.72%
Tr6m	14.38%
Volume	225,060

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BME/ROVI dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.5%

$0.94 annual per share

Payout ratio

+36.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+10.9%

0 consecutive years of growth

Total shareholder yield

+1.5%

Next ex-dividend date: 2026-07-13

Performance

BME/ROVI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BME/ROVI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.3%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

BME/ROVI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

15.7

Below 30: short-term oversold

Price vs 200-day MA

-6.1%

50/200-day relationship not available

Beta (5Y)

0.30

Less volatile than the market

Sharpe ratio

0.62

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BME/ROVI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bme/ROVI stock rating?

bme/ROVI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bme/ROVI analysis?

The full report lives at /stocks/bme/ROVI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bme/ROVI?

The latest report frames bme/ROVI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bme/ROVI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.